ResultsIQ

ResultsIQ › Latest results › Acutaas Chemicals Limited

Acutaas Chemicals Limited Q2 FY27 earnings call summary

NSE: ACUTAAS · BSE: 543349

Earnings call of 27 Oct 2026, summarised by AI from the filing.

Acutaas Q2 FY27 revenue rose 42.7% to ₹4,369 million and it raised FY27 guidance to around 30% growth and 38%-40% EBITDA margin.

Key takeaways

  1. Guidance FY27 revenue growth guidance raised to around 30% and EBITDA margin to 38%-40%.
  2. CDMO pull-forward CDMO revenue target of ₹1,000 cr now expected in FY27, one year ahead of schedule.
  3. Pharma driver Pharma intermediates revenue ₹4,020 million, up 53.1%, on CDMO growth and new product ramp-up.
  4. Specialty drag Specialty Chemical revenue ₹349 million, down 20% Y-o-Y on legacy phase-out and the BFC shipment pause.

Original filing on BSE

Acutaas Chemicals Limited Q2 FY27 results

As filed: Revenue ₹437 cr (+43% year on year), EBITDA ₹176 cr (+85% year on year), PAT ₹123 cr (+71% year on year), EBITDA margin 40.3% (+923 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹330 cr (+59% year on year), EBITDA ₹113 cr (+122% year on year), PAT ₹75.0 cr (+70% year on year), EBITDA margin 34.3% (+966 bps). Score 85 of 100, Above trend. EBITDA margin rose 966 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 24% from last quarter. Share price after the results: −8.4% in 28 days (Nifty 500: +2.4%).
  • Q4 FY26: Revenue ₹422 cr, EBITDA ₹181 cr, PAT ₹137 cr, EBITDA margin 43.0%. Not scored. No result for the same quarter last year. Share price after the results: +25.2% in 29 days (Nifty 500: −0.9%).
  • Q3 FY26: Revenue ₹391 cr, EBITDA ₹154 cr, PAT ₹112 cr, EBITDA margin 39.5%. Not scored. No result for the same quarter last year. Share price after the results: +30.9% in 30 days (Nifty 500: +1.5%).
  • Q2 FY26: Revenue ₹305 cr, EBITDA ₹97.0 cr, PAT ₹73.0 cr, EBITDA margin 31.8%. Not scored. No result for the same quarter last year. Share price after the results: +10.2% in 28 days (Nifty 500: +1.2%).
  • Q1 FY26: Revenue ₹206 cr, EBITDA ₹51.0 cr, PAT ₹45.0 cr, EBITDA margin 24.8%. Not scored. No result for the same quarter last year. Share price after the results: +20.5% in 30 days (Nifty 500: −2.4%).

Past price moves after results do not indicate future moves. Not a recommendation.

Acutaas Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.